Latest Media Releases

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Immutep granted European patent for IMP761 (ASX:IMM)

Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune disease, is ...read more

Immutep to present AIPAC Overall Survival data at SABCS 2020 (ASX:IMM)

Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune disease, is ...read more

IVE Group - Divestment of IVE Telefundraising (Pareto Phone) (ASX:IGL)

IVE Group Limited (ASX:IGL) (IVE) today announces it has signed a binding agreement to divest of its IVE Telefundraising business (Pareto Phone Pty Ltd ACN 115 781 827). The business will be acquire...read more

Immutep - Change in substantial holding (ASX:IMM)

To view the Notice of change of interests of substantial holder, download the attached PDF.

Immutep - Change of Director's Interest Notice - Mr Chamberlain (ASX:IMM)

To view the Change of Director’s Interest Notice, download the attached PDF.

Immutep - Change of Director's Interest Notice - Mr Meyers (ASX:IMM)

To view the Change of Director’s Interest Notice, download the attached PDF.

Immutep - Change of Directors Interest Notice (ASX:IMM)

To view the Change of Director’s Interest Notice, download the attached PDF.

Immutep - Appendix 2A (ASX:IMM)

To view the Application for quotation of +securities, download the attached PDF.

Immutep - Appendix 3G (ASX:IMM)

To view the Notification of issue, conversion or payment up of equity +securities, download the attached PDF.

Immutep - Annual Report filed on Form 20-F with SEC (ASX:IMM)

To view the form, download the attached PDF.

Immutep - Notice of Annual General Meeting/Proxy Form (ASX:IMM)

Immutep Limited (the Company) is convening its 2020 Annual General Meeting (AGM) at 10:30 am (AEDT) on Tuesday, 27th October 2020. Due to the COVID-19 pandemic and related issues, the AGM will be...read more

Immutep - Appendix 4G & Corporate Governance Statement (ASX:IMM)

To view the appendix, download the attached PDF.

Immutep - Annual Report to shareholders (ASX:IMM)

To view the report, download the attached PDF.

Immutep - Improving results from stage 1 of TACTI-002 ph II trial (ASX:IMM)

Immutep Limited (ASX: IMM; NASDAQ: IMMP) announces new interim data from its ongoing Phase II TACTI-002 study. The data was presented in two poster presentations at the ESMO Virtual Congress 2020 on...read more

Immutep reports improving results from INSIGHT-004 trial (ASX:IMM)

Immutep Limited (ASX: IMM; NASDAQ: IMMP) is pleased to report further interim data from its ongoing INSIGHT-004 Phase I clinical trial. The data were presented at the ESMO Virtual Congress 2020 on 1...read more

Viewing: 1 - 15 of 200 Previous | Next